ARTG Medical Device Inclusion vs Conformity Assessment: Who Does What And When

ARTG Medical Device Inclusion

Inclusion of an in-scope medical device in the Australian Register of Therapeutic Goods before supply in Australia.

Distinguishing ARTG inclusion from conformity assessment is critical for manufacturers, sponsors, and supply-chain partners. Conformity assessment is the technical process that demonstrates a device meets regulatory requirements; ARTG inclusion is the administrative outcome recorded by the Therapeutic Goods Administration (TGA) that permits supply. Both are required for most devices, but they serve different roles and are completed by different parties.

Conformity Assessment: The Technical Evidence

Conformity assessment covers testing, quality management, and certification activities that demonstrate a device complies with the Essential Principles and relevant standards. For medium- and high-risk devices this often involves a conformity assessment body (notified body equivalent) or TGA assessment pathways, and can include audits of the manufacturer’s quality management system (for example, ISO 13485).

Manufacturers typically lead conformity assessment: they perform testing, supply technical documentation, and obtain third-party certificates where required. The evidence produced is later submitted by the sponsor as part of the ARTG application.

ARTG Inclusion: The Administrative Listing

Once conformity assessment evidence exists, the sponsor compiles an ARTG application. The TGA reviews the submission for completeness and whether the sponsor has provided adequate evidence that the device conforms to regulatory requirements. If satisfied, the TGA grants an ARTG entry and assigns an ARTG number. Inclusion itself does not change the technical status of the device but legally permits its supply in Australia.

Who Is Responsible For Each Step

• Manufacturer Responsibilities: Produce technical files, perform design verification/validation, implement and maintain quality systems, and obtain necessary certificates.
• Sponsor Responsibilities: Submit the ARTG application, provide local contact details, manage post-market obligations (adverse event reporting, recalls) and liaise with the TGA.
• Third-Party Bodies: Conformity assessment bodies or auditors provide independent verification where required for higher risk classes.

Timing And Sequence

Conformity assessment must be completed or at least demonstrably in progress with valid supporting evidence at the time of ARTG submission for many device classes. Sponsors should not expect ARTG inclusion without appropriate technical evidence. In practical terms: start conformity activities early, compile the technical file in parallel with commercial planning, then submit the ARTG application when documentation is ready to avoid market delays.

Implications For Supply Chain And Warehousing

From a logistics perspective, a warehouse can receive devices only if the sponsor has the legal right to import and supply — demonstrated by ARTG inclusion for the device or a valid import permit in limited circumstances. Carriers and customs brokers seeking to clear medical devices should confirm both that conformity certificates exist (if requested by customs) and that the ARTG number is provided for clearance and labeling checks. Furthermore, post-inclusion obligations (vigilance, corrective actions) mean that warehouses should retain records to support traceability and potential recalls.

Practical Example: A Class IIb Device

A manufacturer completes biocompatibility testing and secures a conformity certificate from an accredited body. The Australian sponsor submits those test reports and the certificate as part of the ARTG application. The TGA reviews the evidence and grants an ARTG number. Only after inclusion does the sponsor arrange commercial importation and instruct the 3PL to receive and distribute stock to retail partners.

Quick Tips To Coordinate Conformity And Inclusion

• Parallel Planning: Align conformity assessment schedules with ARTG application timelines to prevent market-entry gaps.
• Clear Responsibilities: Document who (manufacturer or sponsor) will hold each piece of evidence and who will communicate ARTG numbers to supply-chain partners.
• WMS Integration: Store ARTG numbers and conformity-certificate references within inventory records for audit and recall readiness.

In short, the ARTG Medical Device Inclusion is the regulatory listing that allows supply in Australia, while conformity assessment is the technical verification that supports that listing; both must be coordinated between manufacturers, sponsors and supply-chain partners to ensure lawful, timely distribution and to maintain traceability and post-market compliance.